A Southwest Oncology Group randomized phase II study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer

Gary H. Lyman, Stephanie J. Green, Peter M. Ravdin, Charles E. Geyer, Christy A. Russell, Stanley P. Balcerzak, G. Thomas Budd, Silvana Martino